Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jacobio Pharmaceuticals Group Co., Ltd. ( (HK:1167) ) has shared an announcement.
Jacobio Pharmaceuticals Group Co., Ltd. announced that parties acting in concert with the company have increased their shareholdings by purchasing 402,000 shares on the open market. This move reflects strong confidence in the company’s development prospects and growth potential, with the concert parties now holding approximately 25.41% of the total issued shares. The increase in shareholding is in line with applicable laws and regulations, and further increases are not ruled out.
The most recent analyst rating on (HK:1167) stock is a Hold with a HK$5.30 price target. To see the full list of analyst forecasts on Jacobio Pharmaceuticals Group Co., Ltd. stock, see the HK:1167 Stock Forecast page.
More about Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development and commercialization of innovative drugs, with a strong emphasis on growth potential and long-term investment value.
Average Trading Volume: 8,099,194
Technical Sentiment Signal: Buy
Current Market Cap: HK$7.92B
See more insights into 1167 stock on TipRanks’ Stock Analysis page.